TRIM21 and interstitial lung disease: On the other hand, in patients with anti-MDA5 antibodies, recent studies demonstrated a significant association between anti-Ro52 antibody positivity and unfavorable outcomes, such as developing RP-ILD and poor prognosis [13,19,20,21,22,23,24].